James Bailey

James Bailey

Auto-generated profile, based on publicly available information

James Bailey

Research Department of Primary Care and Population Health, University College London, London, UK

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2025 in BMC Medicine
Verified
Journal Article
Open access
PDF file
ASAida Seyedsalehi
Aida Seyedsalehi
JBJames Bailey
James Bailey
MOMaya G. T. Ogonah
Maya G. T. Ogonah
TFThomas R Fanshawe
Thomas R Fanshawe
SFSeena B. Fazel
Seena B. Fazel
Background: The number of prediction models for self-harm and suicide has grown substantially in recent years. However, their potential role in improving assessment of suicide risk is debated. In this systematic review, we provide an overview and critical appraisal of the predictive performance and methodological quality of prognostic risk models for self-harm and suicide. Methods: We searched MEDLINE, EMBASE, PsycINFO, CINAHL, and Global Health from inception to 30/11/2021. The search was updated on 25/10/2024 to include new external validations. We included studies describing the development and/or external validation of statistical models for predicting risk of non-fatal self-harm and/or death by suicide. Risk of bias was assessed using the Prediction model Risk Of Bias ASsessment Tool (PROBAST). Results: We included 91 articles describing the development of 167 models and 29 external validations. Most models predicted risk of self-harm (76 models), followed by suicide (51 models), and the composite outcome of suicide or non-fatal self-harm (40 models). Only 8% of developed models (14/167) were externally validated, and 17% (28/167) were presented in a format enabling validation or use by others. The reported C indices ranged from 0.61 to 0.97 (median 0.82) in development studies and from 0.60 to 0.86 (median 0.81) in external validations. Calibration was assessed for 9% of models (15/167) in development studies and 31% of external validations (9/29). Of these, the OxMIS and Simon models showed adequate discrimination and calibration performance in external validation. All model development studies, and all but two external validations, were at high risk of bias. This was mainly driven by inappropriate or incomplete evaluation of predictive performance (180/196, 92%), insufficient sample sizes (151/196, 77%), inappropriate handling of missing data (129/196, 66%), and not adequately accounting for overfitting and optimism during model development (106/167, 63%). Conclusions: Despite skepticism about the feasibility and accuracy of self-harm and suicide risk prediction and assessment, we have identified five models with good predictive performance in external validation. Avoidable sources of research waste include an oversupply of unvalidated prediction models addressing similar research questions, and shortcomings in study design, conduct, and statistical analysis. To address these, new research must prioritise methodological rigour and focus on external validation and updating existing models. Complete, transparent, and accurate reporting is essential, with model presentation in a format that enables independent validation.

14 March 2021 in Drug and Alcohol Review
Verified
Journal Article
Open access
PDF file
JBJames Bailey
James Bailey
NKNicola J. Kalk
Nicola J. Kalk
RARebecca Andrews
Rebecca Andrews
SYSarah Yates
Sarah Yates
LNLimon Nahar
Limon Nahar
SPSusan Paterson
Susan Paterson
Introduction: This study investigates whether there is a relationship between alcohol and cocaine use in deaths where suicide by self‐injury is the suspected cause of death.Methods: Adults referred by coroners to the Imperial College London Toxicology Unit for toxicological analysis between 2012 and 2016 were reviewed for inclusion criteria. Those who died by self‐injury reasoned to be deliberate were included in the analysis. Femoral blood alcohol concentration (BAC) and presence of cocaine or benzoylecognine (a metabolite of cocaine) in blood and/or urine were tabulated and odds ratios calculated.Results: A total of 1722 decedents met inclusion criteria. BAC was ≥50 mg/dL in 29% of decedents. Cocaine was detected in 8.4% of cases. The likelihood of testing positive for cocaine increased with BAC and was most frequent between 100 and 199 mg/dL, consistent with moderate to severe intoxication (odds ratio 5.88, 95% confidence interval 3.80, 9.09; P ≤ 0.001) compared to those with BAC <10 mg/dL.Discussion and Conclusions: This study demonstrates a correlation between increasing BAC and likelihood of cocaine use prior to suspected suicide, up to a level consistent with severe intoxication. Cocaine use was found in a high proportion of cases relative to the general population reporting regular use. This pattern of drug and alcohol use has previously been given little attention in suicide prevention strategies and clinical prioritisation.

25 August 2025 in eClinicalMedicine
Verified
Journal Article
Open access
JBJames Bailey
James Bailey
PSPatricia Schartau
Patricia Schartau
SFSeena Fazel
Seena Fazel
INIrwin Nazareth
Irwin Nazareth
IPIrene Petersen
Irene Petersen
The risk of suicide following first diagnosis of depression or anxiety in primary care is uncertain. We investigated suicide incidence within two years of a first diagnosis of depression, anxiety, or mixed anxiety and depression in primary care, analysing variation by diagnosis, age, sex, and social deprivation at lower layer Super Output Area level. We conducted a cohort study using the Clinical Practice Research Datalink, a large primary care electronic health records database, linked to mortality records. Adults with their first diagnosis of depression, anxiety, or mixed anxiety and depression between 1 January 1999 and 31 December 2018 were included. The outcome was suicides per 100,000 person-years at risk (PYAR) within two years of diagnosis. Adjusted incidence rate ratios (aIRR) were calculated using Poisson regression. Among 1,454,102 individuals diagnosed there were 1439 suicides within two years of diagnosis. Rates were higher in men across all cohorts. The highest rate for men was after depression diagnosis: 115·85 per 100,000 PYAR (95% confidence interval [CI] 107·60–124·58), five times higher than women: aIRR 4·99 (95% CI 4·29–5·79). For women the highest rate was after a mixed diagnosis: 27·73 per 100,000 PYAR (95% CI 21·70–34·92). The highest rate across all groups was seen in men aged 70+ after a mixed diagnosis: 156·43 per 100,000 PYAR (95% CI 89·41–254·03). There was no association between rate and deprivation. Suicide rates within two years of a diagnosis were higher than the UK general population rate as reported by the Office for National Statistics. Men consistently exhibited higher rates, with men aged 70 and over diagnosed with mixed anxiety and depression experiencing the highest rate. Women aged 50–59 with a first diagnosis of anxiety had over three times the rate of those aged 18–29 at diagnosis. These findings align with findings from other settings and add to the literature by quantifying the effects in primary care. Further analysis is required, particularly for older men and middle-aged women with anxiety-related conditions. James Bailey is funded by a 10.13039/501100000272 National Institute for Health and Care Research Doctoral Fellowship [NIHR302551].